THORNE HEALTHTECH INC (THRN) Stock Fundamental Analysis
USA - NASDAQ:THRN - US8852601090 - Common Stock
10.19 USD
-0.01 (-0.1%)
10.17 USD
-0.02 (-0.2%)
Taking everything into account, THRN scores 5 out of 10 in our fundamental rating. THRN was compared to 34 industry peers in the Personal Care Products industry. Both the profitability and the financial health of THRN get a neutral evaluation. Nothing too spectacular is happening here. THRN is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year THRN was profitable.
THRN had a positive operating cash flow in the past year.
1.2 Ratios
THRN's Return On Assets of 7.20% is fine compared to the rest of the industry. THRN outperforms 75.00% of its industry peers.
THRN has a Return On Equity of 13.21%. This is in the better half of the industry: THRN outperforms 75.00% of its industry peers.
THRN has a Return On Invested Capital of 4.69%. This is comparable to the rest of the industry: THRN outperforms 55.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for THRN is significantly below the industry average of 12.99%.
The 3 year average ROIC (2.99%) for THRN is below the current ROIC(4.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| ROIC | 4.69% |
ROA(3y)2.02%
ROA(5y)N/A
ROE(3y)2.55%
ROE(5y)N/A
ROIC(3y)2.99%
ROIC(5y)N/A
1.3 Margins
THRN has a better Profit Margin (7.94%) than 70.00% of its industry peers.
Looking at the Operating Margin, with a value of 5.26%, THRN is in line with its industry, outperforming 55.00% of the companies in the same industry.
Looking at the Gross Margin, with a value of 50.15%, THRN is in line with its industry, outperforming 47.50% of the companies in the same industry.
In the last couple of years the Gross Margin of THRN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | 7.94% | ||
| GM | 50.15% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.81%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), THRN is destroying value.
THRN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, THRN has a worse debt to assets ratio.
2.2 Solvency
THRN has an Altman-Z score of 3.41. This indicates that THRN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of THRN (3.41) is better than 67.50% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that THRN is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.17, THRN perfoms like the industry average, outperforming 57.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.41 |
ROIC/WACC0.5
WACC9.44%
2.3 Liquidity
A Current Ratio of 2.41 indicates that THRN has no problem at all paying its short term obligations.
THRN's Current ratio of 2.41 is fine compared to the rest of the industry. THRN outperforms 70.00% of its industry peers.
A Quick Ratio of 1.13 indicates that THRN should not have too much problems paying its short term obligations.
The Quick ratio of THRN (1.13) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.13 |
3. Growth
3.1 Past
THRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 660.00%, which is quite impressive.
THRN shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.25%.
THRN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.66% yearly.
EPS 1Y (TTM)660%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
Revenue 1Y (TTM)23.25%
Revenue growth 3Y30.66%
Revenue growth 5YN/A
Sales Q2Q%29.69%
3.2 Future
THRN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.06% yearly.
THRN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.84% yearly.
EPS Next Y14.31%
EPS Next 2Y46.48%
EPS Next 3Y55.06%
EPS Next 5YN/A
Revenue Next Year23.62%
Revenue Next 2Y24.38%
Revenue Next 3Y21.84%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 26.82, which means the current valuation is very expensive for THRN.
65.00% of the companies in the same industry are more expensive than THRN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.28. THRN is around the same levels.
With a Price/Forward Earnings ratio of 16.38, THRN is valued correctly.
Based on the Price/Forward Earnings ratio, THRN is valued a bit cheaper than 77.50% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 33.61. THRN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 16.38 |
4.2 Price Multiples
THRN's Enterprise Value to EBITDA is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 28.54 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates THRN does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as THRN's earnings are expected to grow with 55.06% in the coming years.
PEG (NY)1.87
PEG (5Y)N/A
EPS Next 2Y46.48%
EPS Next 3Y55.06%
5. Dividend
5.1 Amount
No dividends for THRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.19
-0.01 (-0.1%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners0.03%
Inst Owner Change0%
Ins Owners10.68%
Ins Owner Change0%
Market Cap550.67M
Revenue(TTM)255.95M
Net Income(TTM)20.33M
Analysts80
Price Target8.61 (-15.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-40.77%
Min EPS beat(2)-112.25%
Max EPS beat(2)30.72%
EPS beat(4)2
Avg EPS beat(4)-25.45%
Min EPS beat(4)-112.25%
Max EPS beat(4)30.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-3.4%
Max Revenue beat(2)4.13%
Revenue beat(4)1
Avg Revenue beat(4)-4.4%
Min Revenue beat(4)-9.72%
Max Revenue beat(4)4.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.28%
PT rev (3m)20.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)5.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.81%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 16.38 | ||
| P/S | 2.15 | ||
| P/FCF | N/A | ||
| P/OCF | 25.59 | ||
| P/B | 3.58 | ||
| P/tB | 4.63 | ||
| EV/EBITDA | 28.54 |
EPS(TTM)0.38
EY3.73%
EPS(NY)0.62
Fwd EY6.11%
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)0.4
OCFY3.91%
SpS4.74
BVpS2.85
TBVpS2.2
PEG (NY)1.87
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 13.21% | ||
| ROCE | 5.95% | ||
| ROIC | 4.69% | ||
| ROICexc | 5.07% | ||
| ROICexgc | 6.08% | ||
| OM | 5.26% | ||
| PM (TTM) | 7.94% | ||
| GM | 50.15% | ||
| FCFM | N/A |
ROA(3y)2.02%
ROA(5y)N/A
ROE(3y)2.55%
ROE(5y)N/A
ROIC(3y)2.99%
ROIC(5y)N/A
ROICexc(3y)4.22%
ROICexc(5y)N/A
ROICexgc(3y)5.36%
ROICexgc(5y)N/A
ROCE(3y)3.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.81%
GM growth 5YN/A
F-Score5
Asset Turnover0.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.31 | ||
| Cap/Depr | 590.87% | ||
| Cap/Sales | 14.33% | ||
| Interest Coverage | 19.78 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 3.41 |
F-Score5
WACC9.44%
ROIC/WACC0.5
Cap/Depr(3y)158.15%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)660%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%172.73%
EPS Next Y14.31%
EPS Next 2Y46.48%
EPS Next 3Y55.06%
EPS Next 5YN/A
Revenue 1Y (TTM)23.25%
Revenue growth 3Y30.66%
Revenue growth 5YN/A
Sales Q2Q%29.69%
Revenue Next Year23.62%
Revenue Next 2Y24.38%
Revenue Next 3Y21.84%
Revenue Next 5YN/A
EBIT growth 1Y1143.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year248.89%
EBIT Next 3Y103.9%
EBIT Next 5YN/A
FCF growth 1Y-266.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.29%
OCF growth 3YN/A
OCF growth 5YN/A
THORNE HEALTHTECH INC / THRN FAQ
What is the ChartMill fundamental rating of THORNE HEALTHTECH INC (THRN) stock?
ChartMill assigns a fundamental rating of 4 / 10 to THRN.
What is the valuation status of THORNE HEALTHTECH INC (THRN) stock?
ChartMill assigns a valuation rating of 3 / 10 to THORNE HEALTHTECH INC (THRN). This can be considered as Overvalued.
Can you provide the profitability details for THORNE HEALTHTECH INC?
THORNE HEALTHTECH INC (THRN) has a profitability rating of 4 / 10.
How financially healthy is THORNE HEALTHTECH INC?
The financial health rating of THORNE HEALTHTECH INC (THRN) is 4 / 10.
Can you provide the dividend sustainability for THRN stock?
The dividend rating of THORNE HEALTHTECH INC (THRN) is 0 / 10 and the dividend payout ratio is 0%.